Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients

• Angelo Maiolino,
• Angelo Maiolino,
• Elaine Sobral Da Costa,
• Alberto Orfao

Affiliations

Angelo Maiolino

Department of Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Angelo Maiolino

Department of Hematology, Instituto Americas de Ensino, Pesquisa e Inovação, Rio de Janeiro, Brazil

Elaine Sobral Da Costa

Department of Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Alberto Orfao

Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) Institute for Biomedical Research of Salamanca (IBASAL), CIBERONC and Department of Medicine, University of Salamanca, Salamanca, Spain